Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical Practice

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2013 by Otsuka Frankfurt Research Institute GmbH.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Otsuka Frankfurt Research Institute GmbH
ClinicalTrials.gov Identifier:
NCT01228682
First received: October 25, 2010
Last updated: April 30, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2014
  Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)